Cargando…

Modifiable contributing factors to COVID-19: A comprehensive review

The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostoff, Ronald Neil, Briggs, Michael Brandon, Kanduc, Darja, Dewanjee, Saikat, Kandimalla, Ramesh, Shoenfeld, Yehuda, Porter, Alan L., Tsatsakis, Aristidis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/
https://www.ncbi.nlm.nih.gov/pubmed/36450305
http://dx.doi.org/10.1016/j.fct.2022.113511
_version_ 1784839562701307904
author Kostoff, Ronald Neil
Briggs, Michael Brandon
Kanduc, Darja
Dewanjee, Saikat
Kandimalla, Ramesh
Shoenfeld, Yehuda
Porter, Alan L.
Tsatsakis, Aristidis
author_facet Kostoff, Ronald Neil
Briggs, Michael Brandon
Kanduc, Darja
Dewanjee, Saikat
Kandimalla, Ramesh
Shoenfeld, Yehuda
Porter, Alan L.
Tsatsakis, Aristidis
author_sort Kostoff, Ronald Neil
collection PubMed
description The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. The current study identifies eighty immune system dysfunction-enabling toxic stressors and behaviors (hereafter called modifiable contributing factors (CFs)) that also link directly to COVID-19. Each CF is assigned to one of the five categories in the CF taxonomy shown in Section 3.3.: Lifestyle (e.g., diet, substance abuse); Iatrogenic (e.g., drugs, surgery); Biotoxins (e.g., micro-organisms, mycotoxins); Occupational/Environmental (e.g., heavy metals, pesticides); Psychosocial/Socioeconomic (e.g., chronic stress, lower education). The current study shows how each modifiable factor contributes to decreased immune system capability, increased inflammation and coagulation, and increased neural damage and neurodegeneration. It is unclear how real progress can be made in combatting COVID-19 and other similar diseases caused by viral variants without addressing and eliminating these modifiable CFs.
format Online
Article
Text
id pubmed-9701571
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97015712022-11-28 Modifiable contributing factors to COVID-19: A comprehensive review Kostoff, Ronald Neil Briggs, Michael Brandon Kanduc, Darja Dewanjee, Saikat Kandimalla, Ramesh Shoenfeld, Yehuda Porter, Alan L. Tsatsakis, Aristidis Food Chem Toxicol Review The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. The current study identifies eighty immune system dysfunction-enabling toxic stressors and behaviors (hereafter called modifiable contributing factors (CFs)) that also link directly to COVID-19. Each CF is assigned to one of the five categories in the CF taxonomy shown in Section 3.3.: Lifestyle (e.g., diet, substance abuse); Iatrogenic (e.g., drugs, surgery); Biotoxins (e.g., micro-organisms, mycotoxins); Occupational/Environmental (e.g., heavy metals, pesticides); Psychosocial/Socioeconomic (e.g., chronic stress, lower education). The current study shows how each modifiable factor contributes to decreased immune system capability, increased inflammation and coagulation, and increased neural damage and neurodegeneration. It is unclear how real progress can be made in combatting COVID-19 and other similar diseases caused by viral variants without addressing and eliminating these modifiable CFs. Elsevier Ltd. 2023-01 2022-11-28 /pmc/articles/PMC9701571/ /pubmed/36450305 http://dx.doi.org/10.1016/j.fct.2022.113511 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Kostoff, Ronald Neil
Briggs, Michael Brandon
Kanduc, Darja
Dewanjee, Saikat
Kandimalla, Ramesh
Shoenfeld, Yehuda
Porter, Alan L.
Tsatsakis, Aristidis
Modifiable contributing factors to COVID-19: A comprehensive review
title Modifiable contributing factors to COVID-19: A comprehensive review
title_full Modifiable contributing factors to COVID-19: A comprehensive review
title_fullStr Modifiable contributing factors to COVID-19: A comprehensive review
title_full_unstemmed Modifiable contributing factors to COVID-19: A comprehensive review
title_short Modifiable contributing factors to COVID-19: A comprehensive review
title_sort modifiable contributing factors to covid-19: a comprehensive review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701571/
https://www.ncbi.nlm.nih.gov/pubmed/36450305
http://dx.doi.org/10.1016/j.fct.2022.113511
work_keys_str_mv AT kostoffronaldneil modifiablecontributingfactorstocovid19acomprehensivereview
AT briggsmichaelbrandon modifiablecontributingfactorstocovid19acomprehensivereview
AT kanducdarja modifiablecontributingfactorstocovid19acomprehensivereview
AT dewanjeesaikat modifiablecontributingfactorstocovid19acomprehensivereview
AT kandimallaramesh modifiablecontributingfactorstocovid19acomprehensivereview
AT shoenfeldyehuda modifiablecontributingfactorstocovid19acomprehensivereview
AT porteralanl modifiablecontributingfactorstocovid19acomprehensivereview
AT tsatsakisaristidis modifiablecontributingfactorstocovid19acomprehensivereview